Cardiovascular and Respiratory Assessment Using Biometric Signals in a Non-contact Monitoring Device
Sponsor: Intelomed, Inc.
Terminated
Inability to demonstrate efficacy. The reason for this is that we were unable to get the necessary information from our population of dialysis patient using the mCVI™ non-contact facial tracking cell phone app.
Other terminated trials from Intelomed, Inc.
More terminations from Intelomed, Inc.
Other End-stage Renal Disease trials with similar outcome
Listed as NCT03661229, this NA trial focuses on End-stage Renal Disease and remains terminated or withdrawn. Sponsored by Intelomed, Inc., it has been updated 10 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Apr 2025 — Present [monthly]
Terminated NA
-
Jan 2025 — Apr 2025 [monthly]
Terminated NA
-
Sep 2024 — Jan 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Sep 2021 — Dec 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated · Phase: None → NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Apr 2019 — Jan 2021 [monthly]
Recruiting
-
Dec 2018 — Apr 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2018 — Dec 2018 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Intelomed, Inc.
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
For direct contact, visit the study record on ClinicalTrials.gov .